AJ

Abhishek Jain

Active Director Director DIN 02134163
DIN 02134163 First appointment Jan 2007 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2007
Shareholding value •••• Premium profile

About Abhishek Jain

Data last updated:

Abhishek Jain is a Director at Crimson Laboratories Pvt Ltd (since 2007). The company operates in Healthcare. Crimson Laboratories Pvt Ltd reported revenue of ₹1.52 Cr (FY 2025).

DIN 02134163
Primary Designation Director
Industry Healthcare
First Appointment 01 Jan 2007
Oldest Company Age 36 yrs
Largest company Crimson Laboratories Pvt Ltd · ₹1.52 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Crimson Laboratories Pvt Ltd U24232MP1990PTC005795
Director01 Jan 20071990₹1.52 Cr (FY 2025)Active

Board colleagues of Abhishek Jain

Directorship timeline

Open interactive timeline →
Crimson Laboratories Pvt Ltd
Premium access

Shareholding and investment profile for Abhishek Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Jain

Abhishek Jain currently holds 1 directorship: Crimson Laboratories Pvt Ltd (Director, since 01 Jan 2007, revenue ₹1.52 Cr (FY 2025)).

Abhishek Jain was first appointed on 01 Jan 2007 as Director at Crimson Laboratories Pvt Ltd.

The current boards of Abhishek Jain's companies include Abhinav Jain (Crimson Laboratories Pvt Ltd), Ravi Deo Sharma (Crimson Laboratories Pvt Ltd), Yashvardhan Jain (Crimson Laboratories Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available